Over the past decades, functional group manipulation of aromatic precursors has been a common strategy to access new aromatic compounds. However, these classical methods, such as Friedel-Crafts alkylations and electrophilic/nucleophilic aromatic substitutions, have shown lack of regioselectivity besides the use of activators in excess amounts. To this end, numerous benzannulations to form benzo-fused substrates via Diels-Alder (DA), ring-closing metathesis (RCM), cycloaddition, and transition-metal-promoted processes have been reported. Appending a benzene ring directly onto a pre-existing ring is preferable to many classical methods due to the likely reduction of reaction steps and superior regiocontrol. However, many of these benzannulation reactions require air- and/or moisture- sensitive reaction conditions, a last oxidation step, or the use of highly functionalized precursors. Here we disclose three ‘complementary’ intramolecular ring-opening benzannulations to access a large array of functionalized (hetero)aromatic scaffolds utilizing cyclopropenes-3,3-dicarbonyls, alkylidene cyclopropanes-1,1-diesters, and 2,3-dihydrofuran O,O- and N,O- acetals as building blocks. More than 70 benzo-fused aromatic compounds were synthesized using this complementary approach with yields up to 98% and low catalyst loadings. With these benzannulation reactions in hand, we aim to open the synthetic door to a handful of bioactive natural products.

Over the past decades, functional group manipulation of aromatic precursors has been a common strategy to access new aromatic compounds. However, these classical methods, such as Friedel-Crafts alkylations and electrophilic/nucleophilic aromatic substitutions, have shown lack of regioselectivity besides the use of activators in excess amounts. To this end, numerous benzannulations to form benzo-fused substrates via Diels-Alder (DA), ring-closing metathesis (RCM), cycloaddition, and transition-metal-promoted processes have been reported. Appending a benzene ring directly onto a pre-existing ring is preferable to many classical methods due to the likely reduction of reaction steps and superior regiocontrol. However, many of these benzannulation reactions require air- and/or moisture- sensitive reaction conditions, a last oxidation step, or the use of highly functionalized precursors. Here we disclose three ‘complementary’ intramolecular ring-opening benzannulations to access a large array of functionalized (hetero)aromatic scaffolds utilizing cyclopropenes-3,3-dicarbonyls, alkylidene cyclopropanes-1,1-diesters, and 2,3-dihydrofuran O,O- and N,O- acetals as building blocks. More than 70 benzo-fused aromatic compounds were synthesized using this complementary approach with yields up to 98% and low catalyst loadings. With these benzannulation reactions in hand, we aim to open the synthetic door to a handful of bioactive natural products.

The development of novel targeted therapeutics for the treatment of cancer remains difficult due to the complex nature of the disease itself as well as the challenges associated with the synthesis of these therapeutics. Impediments to the discovery of novel drug candidates include lack of available starting materials and access to well-developed syntheses which are both convenient and economically feasible. Semicarbazides, for instance, are a critical synthon for the manufacture of numerous biologically important molecules. Historically, convenient methods for the synthesis of semicarbazides and their derivatives did not exist. Recently, a facile and efficient method for the preparation of semicarbazides via their corresponding phenyl carbamates was developed. These phenyl carbamate intermediates may also be used to prepare a wide variety of other derivatives such as substituted ureas as well as the aryl carbamoyl derivatives of 1,3-diazinane-5-carboxamide. While exploring the preparation of the aryl carbamoyl derivatives of 1,3-diazinane-5-carboxamide, it was found that these compounds possess anti-cancer activity against the glioblastoma LN-229 cell line. Intrigued by these results, additional analogues were designed, leading to the development of a small library of chromenopyrimidinedione and pyrimidinequinolinedione compounds as potential anti-cancer agents. Indeed, these two classes of compounds, with many of the derivatives novel, produced a selection of interesting molecules with potent anti-cancer activity against the glioblastoma cell line LN-229 at biologically relevant concentrations. Taken together, these results provide a unique approach not only to the design but also towards the synthesis of novel therapeutics intended for use as anti-cancer agents.

Student Number : 0002306V - MSc dissertation - School of Chemistry - Faculty of Science / The first part of the dissertation involves the use of ring closing metathesis (RCM) and ruthenium mediated isomerisation-RCM tandem reactions to form a wide range of nitrogencontaining benzo-fused heterocycles. Those synthesized include the 6-membered isoquinolines, the 7-membered benzazepines and the 8-membered benzazocines. In order to put these compounds into perspective, a review of selected naturally occurring nitrogencontaining benzo-fused heterocycles is included along with some of their synthetic approaches. Of major significance is our utilization of the Wits methodology allowing one to access the 6-, 7- and 8-membered ring systems from a common synthetic intermediate. The 1,2,3,6-tetrahydro-2-benzazocines were all obtained after RCM in excellent yields (82-99%). We were also able to show that some ofthe protecting groups used were easily removed and that the ring could be hydrogenated after RCM to yield the 1,2,3,4,5,6-hexahydro-2- benzazocines. The isoquinolines were synthesized in 78% and 27% yield for the Ac- and Tsprotected compounds respectively, with no product isolated for the Boc- or SO2Bn-protected compounds. These poor results, caused a change to our strategy and we then used a “combinatorial-type” approach for the synthesis of the 2,5-dihydro-1H-2-benzazepines and the 2,3-dihydro-1H-2-benzazepines with yield of 9, 47, 58 and 82% and 8, 26, 39 and 82% obtained respectively for the RCM reaction Futhermore, we attempted the synthesis of the substituted 4-phenyl isoquinolines and 5-phenyl benzazepines, but we found that the systems would not undergo RCM even at high temperatures and with large amounts of Grubbs II metathesis catalyst. A short review is given in the second part of the dissertation concerning the naturally occurring and pharmaceutically useful indenols, indenones and indanones. It further highlights how our methodology was extended to include the synthesis of 4-isopropoxy-5- methoxy-1H-inden-1-ol (X), 4-isopropoxy-5-methoxy-1H-inden-1-one (X) and 4-isopropoxy- 5-methoxy-1H-indanone (X) through the use of ruthenium-mediated isomerisation and RCM from a similar common intermediate. We have shown the synthesis of 3-substituted indenols, indenones and indanones using the same synthetic procedure, but by changing the reaction temperature during RCM. This dissertation also answers many of the questions posed during the post-doctoral work of Coyanis. Namely, we were able to support our proposed mechanism that the conversion of the unsubstituted indenol to the indenone was occurring via a dehydrogenative-oxidation, through the use of 1H NMR studies that were coupled with an ICP-MS analysis. To the best of our knowledge, this is the first reported use of the Grubbs II catalyst (or its degradation products) in a tandem RCM-oxidation procedure by our group recently.